Bluejay Diagnostics, Inc. (BJDX) vs Curis, Inc. (CRIS)

A side-by-side comparison of Bluejay Diagnostics, Inc. and Curis, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Bluejay Diagnostics, Inc. logo
BJDX
Bluejay Diagnostics, Inc.
$837084
$0.81HealthcareDelayed quote: Oct 6, 2026, 1:05 PM EDT
Curis, Inc. logo
CRIS
Curis, Inc.
$1M
$0.75HealthcareDelayed quote: Oct 6, 2026, 12:52 PM EDT

Total return — BJDX vs CRIS

growth of $100 · dividends reinvested · last 5y
BJDX -100.0% (-91.5%/yr)CRIS -100.0% (-80.5%/yr)CRIS compounded faster over this window
Log scale — wide-divergence pair
0000110100Start $10020222023202420252026$0$0
BJDX CRIS

BJDX vs CRIS: by the numbers

  • •CRIS is the larger company ($1M vs $837084 market cap).
  • •Both run net losses; BJDX's is the smaller (0.00% vs -490.33% net margin).

Metrics side by side

Valuation

MetricBJDXCRIS
P/S ratioN/A0.34
P/B ratio0.090.31

Profitability

MetricBJDXCRIS
Gross margin0.00%99.28%
Operating margin0.00%-348.43%
Net margin0.00%-490.33%
ROE-77.23%-450.54%
ROIC-77.55%-567.17%

Growth (annualized)

MetricBJDXCRIS
Revenue CAGR (5Y)N/A-15.88%
Total return CAGR (5Y)N/A-81.06%

Go deeper

Full BJDX analysisFull CRIS analysisInteractive comparison tool

Dig into the metrics

Bluejay Diagnostics ROECuris ROEBluejay Diagnostics operating marginCuris operating marginBluejay Diagnostics revenue growthCuris revenue growthBluejay Diagnostics free cash flowCuris free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.